ArcBest heads into the final trading days of April as the standout outperformer in an otherwise mixed transport sector — up 38% in a month and with Wall Street scrambling to catch up.
The catalyst is clear: ArcBest reported Q1 results on April 28, and the street response has been immediate. Eight firms raised their price targets on April 29 alone. JPMorgan lifted its target from $85 to $117. UBS moved from $98 to $122. TD Cowen went from $97 to $137. Goldman Sachs pushed from $102 to $117. Citigroup raised to $150. Wells Fargo, Truist, and Stifel all moved materially higher too. Despite the upgrades, every firm maintained rather than upgraded its rating — the bulls kept Buy, the sideliners kept Neutral or Hold. That collective target-raising-without-upgrading dynamic tells a specific story: the print impressed, but the 38% run in the prior month had already done much of the work. The mean analyst target now sits at $135, slightly above the current price of $127.76. The valuation has re-rated sharply — the P/E has expanded by nearly 4 points over 30 days, and the P/B has climbed from roughly 1.58 to 2.20.
Options positioning underlines just how aggressively sentiment shifted into the result. The put/call ratio collapsed to 0.12 on April 28 — the lowest reading in the past 52 weeks and nearly three standard deviations below its 20-day mean of 0.36. That is an extreme call-dominated setup, reflecting traders piling into upside exposure rather than hedging. The move from a PCR above 0.40 just two weeks ago to 0.12 today is one of the sharpest sentiment swings in the options market for this name in recent memory.
Short interest sits at 5.5% of the free float, up roughly 12% over the past month — a moderate rebuild, not a dramatic escalation. About 1.24 million shares are short, and the FINRA official data puts days-to-cover at around five days, which is meaningful but not extreme. Borrowing conditions remain loose: cost to borrow is just 0.45%, barely changed on the week. Borrow availability is ample, meaning new shorts face no meaningful friction if they want to lean against the post-earnings rally. The ORTEX short score of 44.6 — roughly mid-range on a 0-100 scale — confirms there is no structural squeeze setup here. This is a stock with real short interest and normal borrow, not a powder-keg.
The peer divergence is worth noting. CVLG gained nearly 12% on the week and HTLD rose about 15%, suggesting the LTL and truckload complex is broadly re-rating, likely on sector-wide relief around freight fundamentals. But XPO fell 10% and WERN dropped 5%, underscoring that the gains are stock-specific rather than a uniform tide. ArcBest's 7.8% weekly gain compares favourably with flat-to-down performance from the rail names — CSX, NSC, and UNP all declined — which suggests investors rotated toward trucking-adjacent names with earnings momentum.
On the factor side, EPS momentum is a genuine strength. The 30-day EPS momentum ranks at the 88th percentile and the 90-day reading is at the 90th percentile — near the top of the universe. The dividend score is also strong at the 89th percentile, though dividend history in the dataset is dated and should not be read as current yield guidance. The EV/EBIT rank is low at the 6th percentile, pointing to a name that is not cheap on earnings power relative to enterprise value. The next scheduled event on the calendar is May 1 — the precise nature and market significance of that event will determine whether the post-earnings momentum has a near-term test.
The question after a month this dramatic is whether the target-lift cycle closes the gap to consensus or whether the stock continues to trade above a Street that is still playing catch-up.
See the live data behind this article on ORTEX.
Open ARCB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
